Dr. Imad George, M.D

NPI: 1346230182
Total Payments
$19,517
2024 Payments
$330.49
Companies
25
Transactions
346
Medicare Patients
1,831
Medicare Billing
$206,434

Payment Breakdown by Category

Food & Beverage$19,330 (99.0%)
Consulting$150.00 (0.8%)
Education$36.86 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $19,330 340 99.0%
Consulting Fee $150.00 1 0.8%
Education $36.86 5 0.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $4,053 59 $0 (2024)
Amgen Inc. $2,754 39 $0 (2024)
Lilly USA, LLC $2,089 39 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $2,023 50 $0 (2023)
Novo Nordisk Inc $1,878 38 $0 (2022)
GlaxoSmithKline, LLC. $1,262 25 $0 (2024)
Merck Sharp & Dohme Corporation $949.35 10 $0 (2019)
PFIZER INC. $679.67 16 $0 (2024)
Gilead Sciences, Inc. $661.67 6 $0 (2020)
Indivior Inc. $533.84 6 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $330.49 7 Amgen Inc. ($141.79)
2023 $728.37 19 Lilly USA, LLC ($272.24)
2022 $1,059 29 Lilly USA, LLC ($262.63)
2021 $1,933 55 AstraZeneca Pharmaceuticals LP ($719.29)
2020 $1,110 34 Lilly USA, LLC ($286.21)
2019 $4,346 59 AstraZeneca Pharmaceuticals LP ($863.23)
2018 $4,892 64 AstraZeneca Pharmaceuticals LP ($1,118)
2017 $5,118 79 Merck Sharp & Dohme Corporation ($691.07)

All Payment Transactions

346 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
09/17/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $16.09 General
Category: RESPIRATORY
09/13/2024 PFIZER INC. VYNDAMAX (Drug) Food and Beverage In-kind items and services $18.00 General
Category: CARDIOVASCULAR
04/01/2024 Lilly USA, LLC JARDIANCE (Drug), ZEPBOUND Food and Beverage In-kind items and services $13.42 General
Category: Diabetes
03/14/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Cardiology
02/13/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Respiratory
02/13/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.80 General
Category: Inflammation
01/17/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.19 General
Category: RESPIRATORY
12/18/2023 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $15.07 General
Category: Opioid Use Disorder
10/27/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), SHINGRIX Food and Beverage In-kind items and services $16.60 General
Category: RESPIRATORY
10/25/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $116.17 General
Category: Diabetes
10/12/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.89 General
Category: Respiratory
09/13/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $120.83 General
Category: Respiratory
09/12/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $17.29 General
Category: Respiratory
08/01/2023 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $15.95 General
07/28/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $19.52 General
Category: Respiratory
07/20/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.59 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/27/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $5.88 General
Category: Cardiovascular and Metabolism
06/20/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.52 General
Category: RESPIRATORY
05/05/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $13.19 General
Category: DIABETES
04/12/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $14.56 General
Category: Diabetes
04/03/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $16.53 General
Category: Respiratory
03/28/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage Cash or cash equivalent $125.00 General
Category: Diabetes
02/28/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $16.51 General
Category: Diabetes
01/24/2023 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $124.99 General
01/23/2023 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug) Food and Beverage In-kind items and services $25.93 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 364 934 $103,305 $51,310
2022 12 430 995 $102,720 $51,699
2021 12 518 1,248 $98,235 $55,006
2020 12 519 1,397 $107,160 $48,419
Total Patients
1,831
Total Services
4,574
Medicare Billing
$206,434
Procedure Codes
46

All Medicare Procedures & Services

46 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 80 554 $72,020 $33,979 47.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 62 62 $12,400 $7,912 63.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 32 48 $8,640 $3,951 45.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 30 50 $3,750 $2,113 56.3%
G0008 Administration of influenza virus vaccine Office 2023 28 28 $1,120 $875.00 78.1%
36415 Insertion of needle into vein for collection of blood sample Office 2023 52 98 $980.00 $806.40 82.3%
20610 Aspiration and/or injection of fluid from large joint Office 2023 12 16 $1,700 $790.86 46.5%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2023 21 21 $525.00 $438.00 83.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 33 40 $2,000 $354.72 17.7%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2023 14 17 $170.00 $90.68 53.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 89 543 $70,590 $33,291 47.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 65 65 $13,000 $8,712 67.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 36 45 $7,550 $4,210 55.8%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 31 49 $3,675 $1,891 51.5%
G0008 Administration of influenza virus vaccine Office 2022 34 34 $1,360 $1,016 74.7%
99441 Telephone medical discussion with physician, 5-10 minutes Office 2022 19 24 $1,440 $948.15 65.8%
90756 Influenza vaccine, quadrivalent derived from cell cultures Office 2022 17 17 $595.00 $479.52 80.6%
36415 Insertion of needle into vein for collection of blood sample Office 2022 60 115 $1,150 $338.16 29.4%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2022 16 16 $400.00 $337.44 84.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 32 36 $1,800 $327.53 18.2%
96372 Injection of drug or substance under skin or into muscle Office 2022 16 26 $910.00 $132.24 14.5%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2022 15 25 $250.00 $16.40 6.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 93 549 $65,295 $36,579 56.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 55 55 $7,760 $7,371 95.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 36 46 $7,130 $3,613 50.7%

About Dr. Imad George, M.D

Dr. Imad George, M.D is a Internal Medicine healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346230182.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imad George, M.D has received a total of $19,517 in payments from pharmaceutical and medical device companies, with $330.49 received in 2024. These payments were reported across 346 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($19,330).

As a Medicare-enrolled provider, George has provided services to 1,831 Medicare beneficiaries, totaling 4,574 services with total Medicare billing of $206,434. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Addiction Medicine
  • Location Livonia, MI
  • Active Since 10/24/2005
  • Last Updated 12/17/2013
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1346230182

Products in Payments

  • FARXIGA (Drug) $2,696
  • TRULICITY (Drug) $1,193
  • JARDIANCE (Drug) $1,137
  • Aimovig (Biological) $966.19
  • BREZTRI (Drug) $732.81
  • Repatha (Biological) $727.57
  • Ozempic (Drug) $701.29
  • Epclusa (Drug) $661.67
  • TRELEGY ELLIPTA (Drug) $653.69
  • SUBLOCADE (Drug) $533.84
  • BELSOMRA (Drug) $509.29
  • Victoza (Drug) $484.85
  • Prolia (Biological) $448.45
  • Zubsolv (Drug) $444.03
  • MOUNJARO (Drug) $362.27
  • Tresiba (Drug) $359.90
  • NATPARA (Drug) $303.85
  • EVENITY (Biological) $301.58
  • INVOKANA (Drug) $298.91
  • BYDUREON (Drug) $292.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Livonia